Timing of Heart Angiography in Heart Attack With Acute Heart Failure
Compares immediate versus delayed heart artery imaging in adults with heart attack and heart failure.
Key facts
- Who runs it
- Chonnam National University Hospital
- Where
- Changwon, Daegu, Daejeon, Gwangju, Jeonju, Jinju, Pusan, Seongnam, Seoul, Suncheon, and Wŏnju, South KoreaSee the 20 sites
- Trial code
- Registry title
- Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
- Status
- Recruiting
- People taking part
- 780 people, planned
- Started
- 15 Jul 2025
- Expected to end
- 30 Apr 2032
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Immediate coronary angiography
- Delayed coronary angiography
- Record updated
- 19 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have a heart attack of the NSTEMI type together with sudden worsening heart failure. It compares an immediate coronary angiography with a delayed one.
- Age
- 19 years or older
- Sex
- Men and women can join.
- Disease stage
- Non-ST-segment elevation myocardial infarction (NSTEMI) with new or worsening shortness of breath (New York Heart Association class 2 or higher) and fluid in the lungs (pulmonary congestion).
- Earlier treatment
- People with a history of coronary artery bypass grafting (CABG), or planned CABG, cannot join.
Main reasons for not taking part
- Cardiogenic shock when first seen
- ST-segment elevation myocardial infarction (STEMI)
- Chest pain (angina) that does not respond to treatment, or life-threatening heart rhythm problems
- Life expectancy under 1 year, or heart failure with a clearly non-ischemic cause
- Pregnancy or breastfeeding
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age ≥19 years
- Non-ST-segment elevation myocardial infarction
- New-onset or worsening of dyspnea (New York Heart Association class ≥2)
- Pulmonary congestion
- Patient's or guardian's consent after understanding the study
Who cannot take part
- ST-segment elevation myocardial infarction; ST-segment elevation ≥0.1 mV in at least 2 contiguous leads, or; New onset left bundle branch block; Posterior wall myocardial infarction
- Refractory angina
- Life threatening ventricular arrhythmias
- History of coronary artery bypass grafting (CABG), or planned CABG
- Cardiogenic shock at initial presentation
- Life expectancy <1 year
- Apparently non-ischemic cause of HF
- Pregnancy and lactation
- Patient's refusal to participate in study
Where in South Korea
- Gyeongsang National University Changwon hospitalChangwon, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Keimyung University Dongsan HospitalDaegu, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Kyungpook National University HospitalDaegu, South KoreaContact: Youngkeun Ahn, ProfessorNot yet recruiting
- Yeongnam University Medical CenterDaegu, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Chungnam National University HospitalDaejeon, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Chonnam National University HospitalGwangju, South KoreaContact: Youngkeun Ahn, Professor (principal investigator)Taking people
- Gwangju Veterans HospitalGwangju, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Kwangju Christian HospitalGwangju, South KoreaContact: Youngkeun Ahn, ProfessorNot yet recruiting
- jeonbuk National University HospitalJeonju, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Gyeongsang National University HospitalJinju, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Dong-A University HospitalPusan, South KoreaContact: Youngkeun Ahn, ProfessorNot yet recruiting
- Seoul National University Bundang HospitalSeongnam, South KoreaContact: Youngkeun Ahn, ProfessorNot yet recruiting
- Asan Medical CenterSeoul, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Koera University Guro HospitalSeoul, South KoreaContact: Youngkeun Ahn, ProfessorNot yet recruiting
- Korea University Anam HospitalSeoul, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Samsung Medical CenterSeoul, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Seoul National University HospitalSeoul, South KoreaContact: Youngkeun Ahn, ProfessorNot yet recruiting
- Kangbuk Samsung Medical CenterSeoul, South KoreaContact: Youngkeun Ahn, ProfessorNo longer taking part
- St. Carollo General HospitalSuncheon, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
- Yonsei University Wonju Severance Christian HospitalWŏnju, South KoreaContact: Youngkeun Ahn, ProfessorTaking people
About the trial
What the trial wants to find out
Study objectives:
Read full original descriptionShow less
To determine the optimal timing of coronary angiography (CAG) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) complicated by acute decompensated heart failure (AHF). The primary objective of this trial is to test the hypothesis that immediate CAG ≤2 hours after establishment of NSTEMI diagnosis would result in a significant reduction in primary composite outcome of death from any cause, non-fatal myocardial infarction (MI), or hospitalization for heart failure (HF) at 12 months after randomization as compared with delayed CAG after stabilization.
Study hypothesis:
Immediate CAG ≤2 hours after establishment of NSTEMI diagnosis would result in a significant reduction in primary composite outcome of death from any cause, non-fatal myocardial infarction (MI), or hospitalization for heart failure (HF) at 12 months after randomization as compared with delayed CAG after stabilization.
Background:
Although current guidelines recommend early CAG within 2 hours for patients with NSTEMI complicated by AHF, many patients with NSTEMI complicated by AHF did not receive early CAG. However, no randomized clinical trials have evaluated the optimal timing of CAG in patients with NSTEMI complicated by AHF. Therefore, the investigators aimed to perform a prospective, investigator-initiated, open-label, muilticenter trial to compare the efficacy and safety between immediate CAG (CAG <2 hours after establishment of NSTEMI diagnosis) and delayed CAG after stabilization (i.e. improved dyspnea and disappearance of pulmonary congestion) in participants with NSTEMI complicated by AHF.
Study procedure:
Following the establishment of NSTEMI diagnosis, participants fulfilling the eligibility criteria will be randomized at a ratio of 1:1 to immediate CAG ≤2 hours after randomization or delayed CAG after stabilization on another day during hospitalization.
The 2 groups in the trial
- Immediate coronary angiography within 2 hours after diagnosis of non-ST-segment elevation myocardialTreatment being tested
Coronary angiography will be performed within 2 hours after diagnosis of non-ST-segment elevation myocardial infarction.
Treatment: Immediate coronary angiography
- Delayed coronary angiography after stabilization of acute decompensated heart failureExisting treatment, for comparison
Coronary angiography will be performed after disappearance of symptoms and signs of acute decompensated heart failure.
Treatment: Delayed coronary angiography
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Trial of IMmediate Invasive Versus Delayed Coronary ANGiography in Non-ST-Segment Elevation Myocardial Infarction Complicated by Acute Decompensated Heart Failure: The TIMING-AHF Trial
- Plain-language title
- Timing of Heart Angiography in Heart Attack With Acute Heart FailureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 19 March 2026